Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.800
+0.050 (1.33%)
At close: Apr 28, 2026
1.33%
Market Cap 104.37M
Revenue (ttm) 34.00M
Net Income (ttm) 8.47M
Shares Out 38.76M
EPS (ttm) 0.22
PE Ratio 12.31
Forward PE n/a
Dividend 0.04 (1.33%)
Ex-Dividend Date May 6, 2026
Volume 8,950
Average Volume 5,613
Open 3.700
Previous Close 3.750
Day's Range 3.650 - 3.800
52-Week Range 3.550 - 4.450
Beta -0.07
RSI 40.19
Earnings Date May 14, 2026

About PEX:BPC

Birzeit Pharmaceuticals Company operates as a pharmaceutical manufacturing company in the Palestinian Authority. The company offers OTC products for alimentary system cardiovascular system, central nervous system, musculo-skeletal system, endocrine, genito-urinary system, diabetes, obstetrics and gynecology infections, affecting nutrition and metabolism, respiratory system, ophthalmic drugs, dermatological preparations, and dietary supplements, as well as ear, nose, and oropharynx therapeutic areas. It serves the Ministry of Health, healthcare ... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 372
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2025, PEX:BPC's revenue was $47.96 million, an increase of 17.98% compared to the previous year's $40.65 million. Earnings were $11.95 million, an increase of 130.54%.

Financial numbers in USD Financial Statements

News

There is no news available yet.